Edition:
United Kingdom

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

6.68HKD
19 Oct 2018
Change (% chg)

HK$0.10 (+1.52%)
Prev Close
HK$6.58
Open
HK$6.45
Day's High
HK$6.83
Day's Low
HK$6.41
Volume
67,046,108
Avg. Vol
59,828,394
52-wk High
HK$13.93
52-wk Low
HK$5.64

Latest Key Developments (Source: Significant Developments)

Sino Biopharmaceutical Says Trustee Further Purchased Shares Of Co For Total Consideration Of HK$48.6 Million
Wednesday, 12 Sep 2018 

Sept 12 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::TRUSTEE FURTHER PURCHASED 6.5 MILLION SHARES OF CO FOR TOTAL CONSIDERATION OF HK$48.6 MILLION.  Full Article

Sino Biopharmaceutical Posts HY Profit Attributable Of RMB1,365.67 Mln
Wednesday, 22 Aug 2018 

Aug 22 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::HY REVENUE RMB9,725.23 MILLION, UP 30.0%.H1 PROFIT ATTRIBUTABLE RMB1,365.67 MILLION 24.1% HIGHER.DECLARED PAYMENT OF A SECOND QUARTERLY DIVIDEND OF HK2 CENTS PER SHARE.  Full Article

Sino Biopharmaceutical Announces Passing Of EU GMP Certification For Tenofovir Production Line
Wednesday, 1 Aug 2018 

Aug 1 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::ANNOUNCES PASSING OF EU GMP CERTIFICATION FOR TENOFOVIR PRODUCTION LINE.  Full Article

Sino Biopharmaceutical Says Obtained Drug Registration Approval For Bortezomib
Friday, 20 Jul 2018 

July 20 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::BORTEZOMIB FOR INJECTION OBTAINED APPROVAL FOR DRUG REGISTRATION BY NATIONAL DRUG ADMINISTRATION -PEOPLE'S REPUBLIC OF CHINA.  Full Article

Sino Biopharmaceutical Says Injection Obtained Drug Registration Approval By National Drug Administration
Wednesday, 27 Jun 2018 

June 27 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::DOCETAXEL INJECTION HAS OBTAINED APPROVAL FOR DRUG REGISTRATION BY NATIONAL DRUG ADMINISTRATION OF PEOPLE'S REPUBLIC OF CHINA.  Full Article

Sino Biopharmaceutical Says Trustee Purchased 5.1 Mln Shares Pursuant To Restricted Share Award Scheme
Friday, 1 Jun 2018 

June 1 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::FROM 23 MAY TO 1 JUNE , TRUSTEE PURCHASED 5.1 MILLION SHARES FROM MARKET TO HOLD ON TRUST FOR PARTICIPANTS FOR HK$97.4 MILLION.  Full Article

Sino Biopharmaceutical Posts Qtrly Net Profit Of RMB771.1 Mln
Friday, 18 May 2018 

May 18 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::QTRLY REVENUE WAS ABOUT RMB4,652.61 MILLION, UP 20.4%.QTRLY NET PROFIT RMB771.1 MILLION VERSUS RMB 579 MILLION.DECLARED PAYMENT OF A FIRST QUARTERLY DIVIDEND OF HK2 CENTS PER SHARE.  Full Article

Sino Biopharmaceutical Says Compound Sodium Acetate Ringer's Injection Gets Drug Registration Approvals
Wednesday, 2 May 2018 

May 2 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::COMPOUND SODIUM ACETATE RINGER'S INJECTION OBTAINS TWO APPROVALS FOR DRUG REGISTRATION BY CHINA FOOD AND DRUG ADMINISTRATION.  Full Article

Sino Biopharmaceutical Announces Proposed Bonus Issue Of Shares
Tuesday, 17 Apr 2018 

April 17 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::RECOMMENDS A BONUS ISSUE OF SHARES ON BASIS OF ONE BONUS SHARE FOR EVERY TWO EXISTING SHARES HELD BY QUALIFYING SHAREHOLDERS.EXPECTED THAT A TOTAL OF 4.21 BILLION BONUS SHARES WOULD BE ALLOTTED AND ISSUED.  Full Article

Sino Biopharmaceutical Co Announces Acquisition of Sino Biopharm Beijing​ & Super Demand
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::CO TO ACQUIRE SINO BIOPHARM BEIJING​,WHICH OWNS 33.6% OF BEIJING TIDE, BY ISSUING 723.3 MILLION SHARES AT HK$12.73 PER ISSUE SHARE.‍FRANCE INVESTMENT (CHINA 1) GROUP TO SELL 52 PERCENT STAKE IN SUPER DEMAND FOR HK$3.69 BILLION TO CO ​.  Full Article

Hong Kong stocks weighed down by falls for mainland markets

* HSI down 1.38 pct, with HSCE losing 1.5 pct IT sub-index dropped as much as 3 pct